Cargando…

Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis

BACKGROUND: Pathogenesis of chronic pancreatitis (CP) is still not entirely understood with many patients probably having more than 1 underlying etiology. Besides toxic-metabolic factors, genetics contribute to disease development. Mutations in cystic fibrosis transmembrane conductance regulator (CF...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlosser, Tobias, Fischer, Daniel, Büttner, Sandra, Blank, Valentin, Hoffmeister, Albrecht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878632/
https://www.ncbi.nlm.nih.gov/pubmed/35212296
http://dx.doi.org/10.1097/MD.0000000000028904
_version_ 1784658705499815936
author Schlosser, Tobias
Fischer, Daniel
Büttner, Sandra
Blank, Valentin
Hoffmeister, Albrecht
author_facet Schlosser, Tobias
Fischer, Daniel
Büttner, Sandra
Blank, Valentin
Hoffmeister, Albrecht
author_sort Schlosser, Tobias
collection PubMed
description BACKGROUND: Pathogenesis of chronic pancreatitis (CP) is still not entirely understood with many patients probably having more than 1 underlying etiology. Besides toxic-metabolic factors, genetics contribute to disease development. Mutations in cystic fibrosis transmembrane conductance regulator (CFTR) are shown to increase risk for CP. Activity of CFTR can easily be accessed in vivo by measurement of nasal potential difference (PD). METHODS: We compared in this monocentric study 17 CP patients from the outpatient unit of our university hospital with 30 healthy controls regarding nasal PDs by using a superfusion protocol. Additionally, demographic and lifestyle data of all persons were recorded. RESULTS: Seventeen patients (12% female, median age 48 years) with CP and 30 healthy volunteers (47% female, 25 years) were included in the study. Patients with CP had a significant higher proportion of CFTR dysfunction (P = .04). Furthermore, demographics differed between the 2 groups with CP patients being older (P < .001). There were differences in daily alcohol consumption (P = .001) and smoking habits (smokers vs nonsmokers: P = .01, pack years: P = .002). CONCLUSIONS: PD measurement is an easily accessible way to show CFTR dysfunction as an etiological factor of CP. Cigarette smoking might impair CFTR function and therefore be 1 preventable cause of CP evolution.
format Online
Article
Text
id pubmed-8878632
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-88786322022-02-28 Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis Schlosser, Tobias Fischer, Daniel Büttner, Sandra Blank, Valentin Hoffmeister, Albrecht Medicine (Baltimore) 4500 BACKGROUND: Pathogenesis of chronic pancreatitis (CP) is still not entirely understood with many patients probably having more than 1 underlying etiology. Besides toxic-metabolic factors, genetics contribute to disease development. Mutations in cystic fibrosis transmembrane conductance regulator (CFTR) are shown to increase risk for CP. Activity of CFTR can easily be accessed in vivo by measurement of nasal potential difference (PD). METHODS: We compared in this monocentric study 17 CP patients from the outpatient unit of our university hospital with 30 healthy controls regarding nasal PDs by using a superfusion protocol. Additionally, demographic and lifestyle data of all persons were recorded. RESULTS: Seventeen patients (12% female, median age 48 years) with CP and 30 healthy volunteers (47% female, 25 years) were included in the study. Patients with CP had a significant higher proportion of CFTR dysfunction (P = .04). Furthermore, demographics differed between the 2 groups with CP patients being older (P < .001). There were differences in daily alcohol consumption (P = .001) and smoking habits (smokers vs nonsmokers: P = .01, pack years: P = .002). CONCLUSIONS: PD measurement is an easily accessible way to show CFTR dysfunction as an etiological factor of CP. Cigarette smoking might impair CFTR function and therefore be 1 preventable cause of CP evolution. Lippincott Williams & Wilkins 2022-02-25 /pmc/articles/PMC8878632/ /pubmed/35212296 http://dx.doi.org/10.1097/MD.0000000000028904 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 4500
Schlosser, Tobias
Fischer, Daniel
Büttner, Sandra
Blank, Valentin
Hoffmeister, Albrecht
Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis
title Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis
title_full Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis
title_fullStr Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis
title_full_unstemmed Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis
title_short Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis
title_sort cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878632/
https://www.ncbi.nlm.nih.gov/pubmed/35212296
http://dx.doi.org/10.1097/MD.0000000000028904
work_keys_str_mv AT schlossertobias cysticfibrosistransmembraneconductanceregulatorfunctioninpatientswithchronicpancreatitis
AT fischerdaniel cysticfibrosistransmembraneconductanceregulatorfunctioninpatientswithchronicpancreatitis
AT buttnersandra cysticfibrosistransmembraneconductanceregulatorfunctioninpatientswithchronicpancreatitis
AT blankvalentin cysticfibrosistransmembraneconductanceregulatorfunctioninpatientswithchronicpancreatitis
AT hoffmeisteralbrecht cysticfibrosistransmembraneconductanceregulatorfunctioninpatientswithchronicpancreatitis